The domestic quarantine authorities plan to announce vaccination plans at the end of this month, including the subject and use of Moderna's bivalent vaccine for COVID-19 omicron.

Moderna bivalent vaccine is still in the pre-application stage, and the intention is to make a plan for use in consideration of the effectiveness and safety of vaccines as well as the quarantine situation and the amount introduced in Korea.

Baek Kyung-ran, head of the Korea Centers for Disease Control and Prevention, answered reporters' questions at a regular briefing on COVID-19 on the 16th.

Moderna's bivalent vaccine "Moderna COVID-19 Spikevax," called the Omicron vaccine, has been officially app